Presentation TCT 2013 Guidelines for Commercial TAVR Site Selection in the United States Presenter: Rhonda Robb October 31, 2013
Presentation TCT 2013 Welcome and Introduction: The Purpose of the FDA Town Hall Meeting Presenter: Martin Leon October 30, 2013
Presentation TCT 2013 Status Update on European Medical Device Regulatory Reform Initiatives Presenter: Alan Fraser October 30, 2013
News Conference News TCT 2013 SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach October 30, 2013
News Conference News TCT 2013 Regulatory Hurdles Pose Challenges for Device Approvals in US, Europe October 30, 2013
Presentation TCT 2013 Medical Device Industry Perspectives Presenter: Michael Mussallem October 30, 2013
Presentation TCT 2013 Keynote Address: The Intersection of Innovation, Payment and Regulatory Approval in the Future of Interventional Cardiology Presenter: Jack Lewin October 30, 2013
Presentation TCT 2013 Keynote Address: FDA-CDRH in the Next Decade – A Vision for Change Presenter: Christy Foreman October 30, 2013
Presentation TCT 2013 Interventional Cardiovascular Medicine Perspectives Presenter: Martin Leon October 30, 2013
Presentation TCT 2013 From Evidence-Based Medicine to Guidelines (and Appropriate Use Criteria) to Clinical Practice Presenter: Robert Harrington October 30, 2013
News Conference News TCT 2013 CRF President Calls for Adaptability in the Face of Innovation, Health Care Reform October 30, 2013
Presentation TCT 2013 Cool and Cath: Critical Appraisal of the New Guidelines Presenter: Timothy Henry October 30, 2013
Presentation TCT 2013 Synthesis of the Current US and EU Guidelines for Management of Multivessel and Left Main Disease (Similarities and Differences) Presenter: Eric Bates October 29, 2013
Presentation TCT 2013 Synthesis of the Current US and EU Guidelines for Management of SIHD (Similarities and Differences) Presenter: Kevin Beatt October 29, 2013
News Conference News TCT 2013 SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines October 29, 2013